Tuberculosis (TB)

New survey investigates levels of resistance to essential TB drugs

The first ever multi-country population-based survey investigating levels of the resistance to essential tuberculosis (TB) drugs was published last week in The Lancet Infectious Diseases. This work was led by the World Health Organization (WHO), in collaboration with National TB Programmes, National TB Reference Laboratories and Supranational Reference Laboratories.

WHO Strategic and Technical Advisory Group for TB meets in Geneva

Geneva, 15 June 2016 - The 16th meeting of WHO’s Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) opened on 13 June 2016 with the appointment of its new Chair, Prof. Ibrahim Abubakar, Director of the Institute for Global Health at the University College London, by WHO’s Director-General. STAG-TB, which is made up of 23 members, advises WHO’s Global TB Programme on all its core functions in the TB response.

WHO launches The Essentials to help guide implementation of the End TB Strategy

Geneva, 16 May - 2016 is the first year of implementation of the WHO End TB Strategy in the context of the United Nations Sustainable Development Goals Agenda, both of which include the aim of ending the TB epidemic. To support the work ahead, the World Health Organization’s Global TB Programme is issuing today operational guidance, The Essentials, for effective adaptation and implementation of the new Strategy as was requested by Member States during the 2014 World Health Assembly.

fact buffet

Lives saved

43 millionlives were saved through effective diagnosis and treatment, 2000-2014.

Fact sheet on tuberculosis

MDR-TB cases

480 000people developed multidrug-resistant tuberculosis (MDR-TB) in the world in 2014.

Q&A on MDR-TB

Funding

1.4 billionUS dollars per year needed to fill resource gap for implementing existing TB interventions.

Global TB report facts
pdf, 450kb